Theranostic Targeting of GRPR and PSMA in Prostate Cancer

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: (WFRF:(Vorobyeva Anzhelika)) > (2023) > Theranostic Targeti...

1 of 7
Previous record
Next record
To hitlist

Details
MARC

Abouzayed, Ayman,1992-Uppsala universitet,Institutionen för läkemedelskemi,Theranostics (author)

Theranostic Targeting of GRPR and PSMA in Prostate Cancer

BookEnglish2023

Publisher, publication year, extent ...

Uppsala :Acta Universitatis Upsaliensis,2023
94 s.
electronicrdacarrier

Numbers

LIBRIS-ID:oai:DiVA.org:uu-501391
ISBN:9789151318288
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-501391URI

Supplementary language notes

Language:English
Summary in:English &language:-1_t

Part of subdatabase

SwePubSwePub

Classification

Subject category:vet swepub-contenttype
Subject category:dok swepub-publicationtype

Series

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy,1651-6192 ;335

Notes

This thesis is based on five original articles that investigated the theranostics of prostate cancer by gastrin-releasing peptide receptor (GRPR) and prostate-specific membrane antigen (PSMA) targeting. GRPR and PSMA are two extensively evaluated prostate cancer cell markers due to their overexpression in the majority of prostate cancer samples. Theranostic targeting of GRPR and PSMA is an attractive strategy to improve the management of prostate cancer patients.Papers I and II focused on the dual targeting of GRPR and PSMA. The effect of linker modification on the affinity for GRPR and PSMA and the pharmacokinetic profile was evaluated. In Paper III, the effect of the GRPR antagonist RM26 conjugation to an albumin-binding domain on the pharmacokinetic profile and its potential use in therapy was investigated. Paper IV focused on developing a GRPR antagonist that was suitable for single-photon emission computed tomography (SPECT) using technetium-99m. In Paper V, the GRPR antagonist developed in Paper IV was translated into a phase I clinical trial to assess safety and dosimetry.Modifying the linkers in GRPR and PSMA heterodimers can largely impact the affinity for both targets. This modification influenced the in vivo targeting specificity and biodistribution, with [125I]I-BO530 in Paper I and [111In]In-BQ7812 in Paper II outperforming other analogues. Our findings in Paper III indicated that the conjugation of an albumin-binding domain to RM26 increased the blood concentration of the radiotracer. This increase led to elevated and stable tumour uptake of [111In]In-DOTA-ABD-RM26 after several days of injection. However, [111In]In-DOTA-ABD-RM26 was also increasingly taken up by various healthy organs. The GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26, studied in Paper IV, showed high specificity and affinity for GRPR. This resulted in elevated GRPR-mediated uptake. Additionally, maSSS-PEG2-RM26 could be radiolabelled via a straightforward radiolabelling protocol. Clinical evaluation of [99mTc]Tc-maSSS-PEG2-RM26 in prostate and breast cancer patients (Paper V) demonstrated the safety and tolerability of the radiotracer, with favourable dosimetry and no side effects.In conclusion, this thesis evaluated different tools for the theranostic targeting of GRPR and PSMA. The findings warrant further investigation to optimise the reported radiotracers.

Subject headings and genre

MEDICIN OCH HÄLSOVETENSKAP Medicinska och farmaceutiska grundvetenskaper Läkemedelskemi hsv//swe
MEDICAL AND HEALTH SCIENCES Basic Medicine Medicinal Chemistry hsv//eng
MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
prostate cancer
gastrin-releasing peptide receptor (GRPR)
prostate-specific membrane antigen (PSMA)
nuclear medicine
molecular imaging
radiotracers
theranostics
Farmaceutisk vetenskap
Pharmaceutical Science
Oncology
Onkologi

Added entries (persons, corporate bodies, meetings, titles ...)

Orlova, Anna,Professor,1960-Uppsala universitet,Institutionen för läkemedelskemi (thesis advisor)
Rosenström, Ulrika,Senior LecturerUppsala universitet,Institutionen för läkemedelskemi (thesis advisor)
Vorobyeva, Anzhelika,Associate ProfessorUppsala universitet,Institutionen för immunologi, genetik och patologi (thesis advisor)
Mitran, Bogdan,ResearcherUppsala universitet,Translationell avbildning med PET,Antaros Medical AB (thesis advisor)
Müller, Cristina,PD Dr.Center for Radiopharmaceutical Sciences, the Paul Scherrer Institute (opponent)
Uppsala universitetInstitutionen för läkemedelskemi (creator_code:org_t)

Internet link

Find in a library

Theranostic Targeting of GRPR and PSMA in Prostate Cancer (Search the publication in LIBRIS)

To the university's database

1 of 7
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Abouzayed, Ayman ...; Orlova, Anna, Pr ...; Rosenström, Ulri ...; Vorobyeva, Anzhe ...; Mitran, Bogdan, ...; Müller, Cristina ...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Basic Medicine; and Medicinal Chemis ...

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Parts in the series: Digital Comprehe ...

By the university: Uppsala University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se